Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Anderson

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|July 17, 2023
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case reportDavid S Buchberger, Samantha K Cook, Peter M Anderson, et al.
Sarcoma|December 12, 2018
Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer DatabaseJoshua M Lawrenz, Gannon L Curtis, Joseph F Styron, et al.
Annals of Surgical Oncology|February 1, 2018
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 TrialAndrea A Hayes-Jordan, Brian A Coakley, Holly L Green, et al.
Sarcoma|May 27, 2020
Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone SarcomaJoshua M Lawrenz, Joseph Featherall, Gannon L Curtis, et al.
Pediatric Blood & Cancer|January 14, 2026
Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric AnalysisJenna Kocsis, Shauna R Campbell, Jonathan Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2009
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcomaColleen M Costelloe, Homer A Macapinlac, John E Madewell, et al.
Pediatric Blood & Cancer|June 26, 2025
Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment FailureAndrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, et al.
Research Square|June 19, 2023
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic SarcomaEashwar Somasundaram, Timothy D Smile, Ahmed Halima, et al.
Scientific Reports|November 7, 2023
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcomaEashwar Somasundaram, Peter M Anderson, Timothy D Smile, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|July 17, 2023
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case reportDavid S Buchberger, Samantha K Cook, Peter M Anderson, et al.
Sarcoma|December 12, 2018
Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer DatabaseJoshua M Lawrenz, Gannon L Curtis, Joseph F Styron, et al.
Annals of Surgical Oncology|February 1, 2018
Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 TrialAndrea A Hayes-Jordan, Brian A Coakley, Holly L Green, et al.
Sarcoma|May 27, 2020
Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone SarcomaJoshua M Lawrenz, Joseph Featherall, Gannon L Curtis, et al.
Pediatric Blood & Cancer|January 14, 2026
Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric AnalysisJenna Kocsis, Shauna R Campbell, Jonathan Jang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing SarcomaPaul A Meyers, Noah Federman, Najat Daw, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2009
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcomaColleen M Costelloe, Homer A Macapinlac, John E Madewell, et al.
Pediatric Blood & Cancer|June 26, 2025
Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment FailureAndrew Muskara, Prarthana B Parthasarathy, Usua Oyarbide, et al.
Research Square|June 19, 2023
Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic SarcomaEashwar Somasundaram, Timothy D Smile, Ahmed Halima, et al.
Scientific Reports|November 7, 2023
Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcomaEashwar Somasundaram, Peter M Anderson, Timothy D Smile, et al.
Pageof 6